Kyolic launches new user-friendly website with enhanced features.

Wakunaga launches new Kyolic 109, Kyo-Red and Kyo-Dophilus plus Cranberry.

Kyolic clinical research presented at Heart & Stroke conference.

Wakunaga becomes exclusive distributor of HerbonĀ® brand in the USA.

Based on extensive stability testing the past decade, Wakunaga announces that they will be extending expiration dates on major Kyo-Dophilus probiotic formulas from 3 to 4 years.

Kyo-Dophilus immuno-stimulatory and anti-inflammatory effects research featured at Neuroscience Symposium and IPA.

Kyolic clinical research presented at American Heart Association conferences.

Kyolic research presented at Experimental Biology conference.